Novel insertional presenilin 1 mutation causing Alzheimer disease with spastic paraparesis. by Foster, Norman L. & Moretti, P.
N eurology
Novel insertional presenilin 1 mutation causing Alzheimer disease with spastic
paraparesis
P. Moretti, A. P. Lieberman, E. A. Wilde, B. I. Giordani, K. J. Kluin, R. A. Koeppe, S. 
Minoshima, D. E. Kuhl, W. K. Seltzer and N. L. Foster 
Neurology 2004;62;1865-1868
This information is current as of March 15, 2007
The online version of this article, along with updated information and services, is
located on the World Wide Web at: 
http://www.neurology.org/cgi/content/full/62/10/1865
Neurology is the official journal of AAN Enterprises, Inc. A bi-monthly publication, it has been 
published continuously since 1951. Copyright © 2004 by AAN Enterprises, Inc. All rights reserved. 
Print ISSN: 0028-3878. Online ISSN: 1526-632X.
Downloaded from www.neurology.org at UNIV UTAH MARRIOTT LIB on March 15, 2007
Novel insertional presenilin 1 mutation 
causing Alzheimer disease with
P. Moretti, MD; A.P. Lieberman, MD; E.A. Wilde, PhD; B.I. Giordani, PhD; K.J. Kluin, MS;
R.A. Koeppe, PhD; S. Minoshima, MD, PhD; D.E. Kuhl, MD; W.K. Seltzer, PhD; and N.L. Foster, MD
Abstract—A four-generation pedigree exhibiting early-onset. autosomal dom inant Alzheimer disease (AD) w ith spastic 
paraplegia, dystonia, and dysarthria due to a novel 6-nucleotide insertional m utation in exon 3 of the presenilin 1 gene 
(PS1) is described. Serial examinations, PET scans, and autopsy revealed th a t the m utation in this highly conserved 
portion of PS1 causes an aggressive dem entia that, m aintains the  usual regional hierarchy of disease pathology while 
extending abnorm alities into more widespread brain areas than  typically seen in AD.
NEUROLOGY 2004;62:1865-1868
D em entia w ith  spastic paraparesis has been re ­
ported in several dom inantly inherited neurologic 
conditions, including early-onset familial Alzheimer 
disease (AD), familial British dem entia w ith amyloid 
angiopathy, hereditary  spastic paraparesis (HSP), 
and G ers tm an n -S trau ss le r-S ch e in k e r syndrom e. 
AD w ith spastic paraparesis is caused by presenilin 
1 gene (P S 1 ) m utations.1-2 Early-onset AD w ith spas­
tic paraparesis was originally reported a t the U ni­
versity  of M ichigan in 1913.3 We describe the  
clinical, metabolic, and pathologic characteristics of 
AD with spastic paraparesis due to a novel P S 1  m u­
tation in an apparently unrelated  Michigan family.
Methods. We examined two siblings with early-onset dementia 
(Cases IV.2 and IV.3) and obtained from family members inform a­
tion about members of three prior generations who had a sim ilar 
illness.
PET with [18F]fluoro-2-deoxy-D-glucose (FDG-PET) was per­
formed in Cases IV.3 and IV.2. Metabolic changes in these sub­
jects were compared with those of 27 patien ts with autopsy- 
confirmed AD, who had no known genetic mutation and varying 
degrees of dem entia severity.18 Additional comparisons were per­
formed with FDG-PET resu lts from 33 normal subjects.
Postmortem brain tissue was fixed in 10% formalin and pro­
cessed for paraffin embedding and immunohistochemical analysis. 
Previously characterized antibodies against (i-amyloid peptide 
(DAKO, C arpinteria, CA), tau  (Sigma Chemical Co., St. Louis, 
MO), and glial fibrillary acidic protein (DAKO) were used accord­
ing to the m anufacturers’ recommendation.
Additional material related to this article can be found on the Neurology 
Web site. Go to www.neurology.org and scroll down the Table of Con­
tents for the May 25 issue to find the title link for this article.
Blood sam ples were taken from Cases IV.3 and IV.2 and their 
unaffected mother. Direct testing for m utations in the coding re ­
gion of the PS1  gene was performed a t A thena Diagnostics, Inc. 
(Worchester, MA) by PCR amplification of genomic DNA and 
cDNA followed by autom ated sequencing of both DNA strands. 
The cDNA tem plate for PCR was prepared by reverse transcrip­
tion of PS1 m essenger RNA purified from blood lymphocytes.
Results. The proband’s paternal great-grandfather (1.1), 
grandfather (II.3), and fa ther (III.3) died in the ir th irties of 
a dem enting illness associated with severe progressive gait 
im pairm ent (see the pedigree in the  supplem entary m ate­
rial on the Neurology Web site; go to www.neurology.org).
The proband (IV.3) developed memory problems a t age 
28 years. By age 31, he had  mild bilateral limb apraxia, 
left-hand dystonia, and brisk stretch  reflexes in the  lower 
extremities. His gait was normal. In itial neuropsychologi­
cal testing showed mild dem entia (table). Laboratory stud­
ies for reversible causes of dem entia were normal, and 
brain MRI showed mild atrophy. FDG-PET dem onstrated 
significant, hypometabolism of the tem poroparietal associa­
tion cortex (figure 1, A), a typical pa ttern  for sporadic AD.7 
The patient, was heterozygous for a novel insertional m u ta­
tion in the PS1 gene (see below), and no PS1 m utations 
were found in his mother. Subsequent, examinations re­
vealed progressive deterioration in cognition and develop­
ment. of language, motor speech, and gait, abnormalities. A 
second FDG-PET scan at. age 33 showed a rem arkable 
increase in the  severity and extent, of glucose hypometabo­
lism (see figure 1, C). At. his last, evaluation at. age 34, the 
patient, was profoundly demented, exhibited severe dysar­
thria, dysphagia, and spasticity of arm s and legs, and was 
unable to stand or am bulate unassisted.
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age 36Age 31 Age 32 Age 33
General intellect Impaired
MMSE, WNL > 23 24 16 9 18
WAIS-R/III, score (percentile)
Full-Scale IQ 69(2nd) 60 (c is t) 63 « l s t )
Verbal IQ 76 (5th) 74 (4th) 66 (1st)
Performance IQ 64 (c is t ) 50 (c is t) 65 (< ls t)
Reading achievement, percentile Impaired
WRAT-R/AMNART 38th 62nd
Language Impaired
Naming, WNL a  47; score (percentile) 5 1 (4th) 45 (c is t) 35 ( c i s t )
Verbal fluency, percentile 9th 4th 45th
Receptive language, percentile 33nd
Visuospatial, percentile Impaired
WMS (/III) copy 16th
Visual discrimination WNL
WAIS-R/III BD < ls t < l s t 2nd
Memory Impaired
Memory quotient, WMS; percentile 8th > l s t
Verbal prose recall, WMS/III; percentile 2nd
% retention 81st 57th
Verbal list learning, HVLT-R; percentile < l s t
Visual recall, WMS/III; percentile 2nd
% retention 67 23
Attention, percentile Impaired
Digit span, WAIS-R/III 2nd 4th
Arithmetic, WAIS-R/III 4th 4th < l s t
Executive functioning, percentile Impaired
Trails-M aking B < l s t
WCST correct responses 3rd 12th
Motor testing, percentile Impaired
Strength of grip, R/L 66th/69th 27th/16th
Tapping, R/L 21st/4th 2 n d /< ls t
Manual dexterity, R/L < ls t /< l s t
By age 33, Case IV.3 was too impaired to participate in the formal tes t m easures listed here, and the Severe Im pairm ent B attery was 
administered: < l-2 n d  percentile = impaired; 3 -8 th  percentile = borderline impaired; 9-23rd  percentile = low average; 24-75 th  per­
centile = average.
MMSE = Mini-Mental S tate Examination; WAIS = Wechsler Adult Intelligence Scale; WRAT = Wide Range Achievement Test; AMN- 
ART = American National Adult Reading Test; WNL = within normal limits; WMS = Wechsler Memory Scale; BD = Block Design; 
HVLT = Hopkins Verbal Learning Test; WCST = Wisconsin Card Sorting Test.
The proband’s 36-year-old right-handed sister (IV.2) 
had  a history of progressive memory problems, gait im ­
pairm ent, and slurred speech. On examination, she had  a 
spastic gait and spasticity in all limbs, although more se­
vere in the legs. She dem onstrated mild dystonic dysar­
th ria , verbal aprax ia, prom inent dysnom ia, and  m ild 
stuttering. Neuropsychological testing  showed significant 
cognitive and motor im pairm ent relative to h er estim ated 
premorbid average abilities (see the  table). Laboratory 
studies and brain MRI were normal, bu t FDG-PET demon­
stra ted  a pa ttern  of hypometabolism sim ilar to h er broth­
er’s (see figure 1, B). She was heterozygous for the same 
insertional PS1  gene m utation detected in  h er affected 
sibling.
FDG-PET scans were performed at different dem entia 
severities (Mini-Mental S tate Exam ination [MMSE] scores 
of 22, 15, and 9). Hypometabolism first developed in the 
posterior tem poroparietal cortex and la te r encompassed 
the posterior cingulate, prim ary motor, and frontal associ­
ation cortices (see figure 1, B and C). The involvement of 
the prim ary motor cortex was apparent only after spastic 
paraparesis was clinically noticeable. The prim ary motor
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Figure 1. Cerebral glucose metabolism  
measured with P E T  following injection 
o f 10 mCi o f [18F]fluorodeoxyglucose. 
Images show the results o f three­
dimensional stereotactic surface projec­
tion (SSP) analysis. Patient studies are 
shown in order o f dementia severity at 
the time o f study (A to C). Case TV.3 
was scanned twice, when his M ini­
M ental State Exam ination (MMSE) 
score was 22 (A) and again when his 
M M SE score was 9 (C). Case TV.2 was 
scanned with moderate dementia when 
her M M SE was 15 (B). In  each panel, 
the four images from left to right show  
the right lateral, left lateral, right me­
dial, and left medial views o f the cere­
bral cortex. Data for each patient study  
are shown in two ways. The first row o f  
each study shows cerebral glucose me­
tabolism relative to that in the pons. 
Colors correspond to values o f relative 
glucose metabolism (white > red > yel­
low >  green >  blue). The second row 
shows statistical S S P  maps derived 
from pixel-by-pixel z scores where me­
tabolism is lower in the patient than in 
33 elderly normal control subjects 
(mean age 68 years, range 58 to 91 
years). In  these statistical maps, the 
same color scale is used, and yellow  
corresponds to a z score o f 3. The last 
panel o f  the figure (D) shows calculated 
images o f relative cerebral glucose me­
tabolism for Alzheim er disease with an  
M M SE score o f 9, comparable with the 
severity o f the patient scanned in (C). The arrows in (C) indicate the sparing o f  the prim ary visual cortex. The arrows in 
(D) indicate the location o f  the prim ary motor cortex, normally spared in Alzheim er disease.
cortex of Case IV.3 exhibited the g reatest change of any 
brain region (3.3 SD compared w ith norm al individuals), 
while his MMSE declined from 22 to 9. In contrast, scans 
from 27 nonfam ilial, autopsy-confirm ed AD patien ts  
showed the greatest changes in association cortex and pos­
terior cingulate gyrus (0.7 to 1.7 SD) as dem entia severity 
increased from MMSE 22 to 9, w ith little change (0.5 SD) 
in the prim ary motor cortex. O ther affected brain areas of 
Case IV.3 also had more rapid decline than  those of typical 
AD subjects (1.9 to 2.7 SD), paralleling the rapid disease 
progression.
Gross examination of Case IV.3 revealed a 1,110-g brain 
w ith m oderate atrophy prim arily involving the frontal and 
tem poral lobes. Microscopic examination showed moderate 
neuron loss and gliosis involving all neocortical regions, 
am ygdala, and hippocam pus. Both large eosinophilic 
p laques w ithout a dense amyloid core (cotton-wool 
p laques)2-8 and typical pathologic features of AD were 
present throughout the  neocortex, limbic regions, and less 
severely in the striatum . No macroscopic degeneration of 
the corticospinal tracts was observed a t the  level of the 
m idbrain. The spinal cord was not collected at the  tim e of 
autopsy.
Sequencing of the PS1 gene revealed a heterozygous
6-nucleotide insertion (TTATAT) a t nucleotide position 715 
of the PS1 cDNA. This m utation is predicted to resu lt in 
the substitution of tyrosine w ith phenylalanine and fol­
lowed by the insertion of isoleucine and tyrosine, resulting 
in the  net addition of phenylalanine and isoleucine be­
tween codons 156 and 157.
D iscu ssio n . Previously reported P S 1  m utations 
causing AD are due to missense m utations, w ith rare  
examples of genomic deletions or insertions of single 
amino acids due to splice site m utations.1'2 9 The m u­
tation  in our pedigree is novel because it  is a 
genomic insertion of 6 nucleotides and is located in 
the region of exon 3 encoding the intracellular loop 
between transm em brane domains 2 and 3 of PS1. 
This region shares significant homology in both PS1 
and PS2 and is highly conserved phylogenetically, 
suggesting it  may have a critical function.
The physiologic implications of this m utation are 
not fully understood. However, several features sug­
gest th a t this novel m utation causes an unusually 
aggressive form of AD: 1) the early age a t onset, 
severity, and rapid progression of neurologic and
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Figure 2. Cotton-wool plaques in fam ilia l Alzheim er d is­
ease, Case IV.3. (A) Round, eosinophilic cotton-wool 
plaques in the hippocampus. Luxol fast blue/cresyl violet/  
eosin; X200. (B) Cotton-wool plaques in the dentate gyrus, 
displacing normal structures. These plaques have a d is­
tinct central pallor on Bielschowsky silver stain. X400. (C) 
Immunohistochemical stain for fi-amyloid protein high­
lights cotton-wool plaques and shows a uniform to periph­
erally accentuated distribution. Less frequent classic 
neuritic plaques are also present and contain a densely 
stained amyloid core. A  blood vessel whose wall is immu- 
noreactive for fi-amyloicl protein is present at the bottom o f  
the field. X200. (D) Am yloid deposition in blood vessel 
wall is highlighted by birefringence in polarized light after 
Congo red stain. X400. (E) Immunohistochemical stain for 
tau reveals uniformly distributed threads throughout the 
cotton-wool plaque. Adjacent neurons contain neurofibril­
lary tangles. X400. (F) Reactive astrocytes located a t the 
periphery o f cotton-wool plaques. Glial fibrillary acidic 
protein immunohistochemistry; X400.
neuropsychological deficits; 2) the development of 
spastic paraparesis , dystonia, and m otor speech 
changes unexpected in AD; 3) the pathologic involve­
m ent of both cortical and subcortical structures to an 
unusual degree; and 4) the more rapid progression 
and wider topographic ex ten t of hypometabolism 
seen by FDG-PET as compared with typical AD.
The patien ts’ in itial cognitive deficits reflected a 
severity typically seen only after several years of 
progression of AD, and Case IV.3 had more than  
twice the m ean rate  of expected cognitive decline.10 
The early development of spastic paraparesis, dysto­
n ia of the upper extremities, and dysarthria  with 
dystonic components indicated a widespread dys­
function of the motor system th a t was confirmed
with FDG-PET scans and neuropathology. Glucose 
hypometabolism of the prim ary motor—sensory cor­
tex was much greater th an  in equally demented typ­
ical patien ts w ith AD6 (see figure 1, D, arrows). 
Cotton-wool p laques and large eosinophilic 
P-amyloid plaques lacking congophilia and with little 
associated neuritic pathology2'8 were present in all 
sections of the neocortex including the motor cortex 
(figure 2). These plaques have been described in 
some cases of AD w ith spastic paraparesis and have 
been proposed to be associated w ith more aggressive 
P S 1  m utations. Fewer plaques and less severe gliosis 
also were noted in the basal ganglia.
Although pathology in th is pedigree is more wide­
spread th an  typical, there is also evidence th a t the 
usual regional hierarchy of disease pathology is pre­
served, with initial damage of memory systems and 
association cortex. FDG-PET showed predom inant 
tem poroparietal hypometabolism expected in spo­
radic AD.7 Like typical patients w ith AD and unlike 
other disorders like HSP, our subjects developed cog­
nitive problems first, although attention later easily 
was diverted to obvious motor symptoms. As a conse­
quence, th is novel insertional P S 1  m utation is a good 
model for AD, exhibiting an accelerated rate  of dis­
ease progression and more extensive topographic dis­
tribution of pathology.
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